97 related articles for article (PubMed ID: 12206026)
1. [Inhibitory effect of tumor necrosis factor and interferon with chemotherapeutic drugs on the growth of cancer cell of tongue].
Qu XR; Shen ZH; He ZM
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):421-2. PubMed ID: 12206026
[No Abstract] [Full Text] [Related]
2. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines.
Matsuo S; Takano S; Yamashita J; Ogawa M
Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224
[TBL] [Abstract][Full Text] [Related]
3. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S
Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454
[TBL] [Abstract][Full Text] [Related]
4. Effects of biological response modifiers on ovarian carcinoma cell lines.
Marth C; Helmberg M; Mayer I; Fuith LC; Daxenbichler G; Dapunt O
Anticancer Res; 1989; 9(2):461-7. PubMed ID: 2502063
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
[TBL] [Abstract][Full Text] [Related]
6. [Anti-cervix-cancer effect of the co-immobilization of tumor necrosis factor-alpha and interferon-gamma].
Guan Y; He L; Cai S; Zhou T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1303-7. PubMed ID: 17228731
[TBL] [Abstract][Full Text] [Related]
7. [Synergistic effects of tumor necrosis factor interferon-gamma and chemotherapeutic drugs on human ovarian cancer cell lines in vitro].
Li J; Hui N; Zhu L
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):429-31. PubMed ID: 8697994
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
Fan QL; Zou WY; Song LH; Wei W
Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
14. Is interferon gamma one key of metastatic potential increase in human bladder carcinoma?
Champelovier P; Simon A; Garrel C; Levacher G; Praloran V; Seigneurin D
Clin Cancer Res; 2003 Oct; 9(12):4562-9. PubMed ID: 14555531
[TBL] [Abstract][Full Text] [Related]
15. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
Lyu MA; Kurzrock R; Rosenblum MG
Biochem Pharmacol; 2008 Feb; 75(4):836-46. PubMed ID: 18082672
[TBL] [Abstract][Full Text] [Related]
16. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Chen W; Zhou X; Xu Q; Guo W; Lin L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
[TBL] [Abstract][Full Text] [Related]
19. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT
Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763
[TBL] [Abstract][Full Text] [Related]
20. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M
Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]